BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 18701508)

  • 1. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
    Raina K; Rajamanickam S; Singh RP; Deep G; Chittezhath M; Agarwal R
    Cancer Res; 2008 Aug; 68(16):6822-30. PubMed ID: 18701508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice.
    Singh RP; Raina K; Sharma G; Agarwal R
    Clin Cancer Res; 2008 Dec; 14(23):7773-80. PubMed ID: 19047104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
    Raina K; Blouin MJ; Singh RP; Majeed N; Deep G; Varghese L; Glodé LM; Greenberg NM; Hwang D; Cohen P; Pollak MN; Agarwal R
    Cancer Res; 2007 Nov; 67(22):11083-91. PubMed ID: 18006855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis.
    Singh RP; Gu M; Agarwal R
    Cancer Res; 2008 Mar; 68(6):2043-50. PubMed ID: 18339887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis.
    Bono AV; Pannellini T; Liberatore M; Montironi R; Cunico SC; Cheng L; Sasso F; Musiani P; Iezzi M
    Anal Quant Cytol Histol; 2010 Jun; 32(3):136-45. PubMed ID: 20701066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of silibinin on the growth and progression of primary lung tumors in mice.
    Singh RP; Deep G; Chittezhath M; Kaur M; Dwyer-Nield LD; Malkinson AM; Agarwal R
    J Natl Cancer Inst; 2006 Jun; 98(12):846-55. PubMed ID: 16788158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
    Singh RP; Sharma G; Dhanalakshmi S; Agarwal C; Agarwal R
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.
    Deep G; Kumar R; Jain AK; Agarwal C; Agarwal R
    Mutat Res; 2014 Oct; 768():35-46. PubMed ID: 25285031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
    Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
    Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
    Shukla S; Bhaskaran N; Babcook MA; Fu P; Maclennan GT; Gupta S
    Carcinogenesis; 2014 Feb; 35(2):452-60. PubMed ID: 24067903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer prevention by silibinin.
    Singh RP; Agarwal R
    Curr Cancer Drug Targets; 2004 Feb; 4(1):1-11. PubMed ID: 14965263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: comparison with silymarin and silibinin.
    Deep G; Raina K; Singh RP; Oberlies NH; Kroll DJ; Agarwal R
    Int J Cancer; 2008 Dec; 123(12):2750-8. PubMed ID: 18798272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis and prostate cancer: identification of a molecular progression switch.
    Huss WJ; Hanrahan CF; Barrios RJ; Simons JW; Greenberg NM
    Cancer Res; 2001 Mar; 61(6):2736-43. PubMed ID: 11289156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling.
    Deeb D; Gao X; Liu Y; Jiang D; Divine GW; Arbab AS; Dulchavsky SA; Gautam SC
    Carcinogenesis; 2011 May; 32(5):757-64. PubMed ID: 21325633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model.
    Ru P; Steele R; Nerurkar PV; Phillips N; Ray RB
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2122-30. PubMed ID: 21911444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling.
    Singh RP; Raina K; Deep G; Chan D; Agarwal R
    Clin Cancer Res; 2009 Jan; 15(2):613-21. PubMed ID: 19147767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model.
    Gupta S; Adhami VM; Subbarayan M; MacLennan GT; Lewin JS; Hafeli UO; Fu P; Mukhtar H
    Cancer Res; 2004 May; 64(9):3334-43. PubMed ID: 15126378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels.
    Singh RP; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R
    Cancer Res; 2002 Jun; 62(11):3063-9. PubMed ID: 12036915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interactions of dietary tomato powder and soy germ on prostate carcinogenesis in the TRAMP model.
    Zuniga KE; Clinton SK; Erdman JW
    Cancer Prev Res (Phila); 2013 Jun; 6(6):548-57. PubMed ID: 23592738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic therapy with Nintedanib affects hypoxia, angiogenesis and apoptosis in the ventral prostate of TRAMP animals.
    da Silva RF; Banzato TP; Alves LF; Carvalho JE; Agarwal R; Cagnon VHA
    Cell Tissue Res; 2020 Feb; 379(2):407-420. PubMed ID: 31473819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.